Viva Star Bioscience
Viva Star Bio is advancing proprietary and differentiated assets (LPAR1 antagonist and NLRP3 inhibitors) for the treatment of respiratory disorders such as pulmonary fibrosis, asthma, etc.
)
January 12-15, 2026 | San Francisco Marriott Marquis, CA
January 12-15, 2026 | San Francisco Marriott Marquis, CA
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)